SPRB

Spruce Biosciences, Inc. Common Stock
SPRB

Overview Fund Activity
Delisted

SPRB was delisted on the 28th of April, 2025.

Back to rankings

36 hedge funds and large institutions have $24.7M invested in Spruce Biosciences, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 5 closing their positions.

Holders
36
Holders Change
-2
Holders Change %
-5.26%
% of All Funds
0.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
7
Reduced
10
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
A
1
Abingworth
United Kingdom
$2.47M
2
B
2
Bailard
California
$29K
3
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$16K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$171K
5
Citadel Advisors
5
Citadel Advisors
Florida
$2.37M

Top Sellers

1
Millennium Management
1
Millennium Management
New York
$199K
2
Goldman Sachs
2
Goldman Sachs
New York
$27K
3
Morgan Stanley
3
Morgan Stanley
New York
$31K
4
VF
4
Virtu Financial
New York
$0
5
E
5
Ergoteles
New York
$32K
Name Holding Trade Value Shares
Change 		Shares
Change %
SG
26
StoneX Group
New York
$13.8K -$2.54K -1,852 -16%
UBS Group
27
UBS Group
Switzerland
$10K +$2.22K +1,664 +28%
TRCT
28
Tower Research Capital (TRC)
New York
$10K +$5.87K +4,302 +142%
Bank of America
29
Bank of America
North Carolina
$2K -$2.33K -1,532 -54%
Federated Hermes
30
Federated Hermes
Pennsylvania
$2K +$244 +137 +14%
Wells Fargo
31
Wells Fargo
California
$1K -$595 -395 -37%
Fidelity Investments
32
Fidelity Investments
Massachusetts
$1K +$2 +1 +0.2%
CAL
33
Capital Advisors Ltd
Ohio
$1K +$812 +515 +433%
VF
34
Virtu Financial
New York
– -$27K -15,738 Closed
Legal & General Group
35
Legal & General Group
United Kingdom
– -$1K -782 Closed
Citigroup
36
Citigroup
New York
– -$1K -393 Closed
1
2